This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Purdy, B. D. Search for Related Content Social Bookmarking                         What's this?

Management and Prevention of Opportunistic Infections in the HIV-Infected Patient

Albany Medical Center, Mail-code 85, 43 New Scotland Avenue, Albany, New York 12208, purdyb{at}mail.amc.edu

With the introduction of potent antiretroviral therapy, the incidence of opportunistic infections (OIs) as well as death has dramatically decreased since 1996. Opportunistic infections are seen mainly in three groups: (1) newly diagnosed patients not receiving antiretroviral therapy and presenting with an OI, (2) patients nonadherent to antiretroviral and OI treatment regimens or (3) patients whose antiretroviral therapy has failed. This article will review the most common opportunistic infections (OIs) seen in the HIV-infected individual and their treatment. The current guidelines for the prophylaxis against these OIs will also be discussed.

Key Words: opportunistic infection • prophylaxis • human immunodeficiency syndrome • highly active antiretroviral therapy (HAART) • CD4+ cell count • viral load

Journal of Pharmacy Practice, Vol. 13, No. 6, 475-498 (2000)
DOI: 10.1106/JDYC-JYVC-XJAA-LJ1F


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?